Kristian Stensland, MD, MPH, MS

 Kristian D. Stensland
Assistant Professor of Urology
Assistant Professor of Learning Health Sciences
Medical School
University of Michigan
Department of Urology
NCRC Building 16; 2800 Plymouth Road
Ann Arbor, Michigan 48109
Available to mentor
Kristian Stensland, MD, MPH, MS
Kristian D. Stensland
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • About

    Dr. Kristian Stensland is a urologic oncologist and health services researcher. His research focuses on improving the conduct, efficiency, and equity of clinical trials through informatics, infrastructure, and implementation science.

    Qualifications
    • MS, Health Infrastructures and Learning Systems
      University of Michigan, Ann Arbor, MI, United States
      2020 - 2021
    • MPH, Quantitative Methods
      Harvard TH Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, United States
      2016 - 2017
    • MD, Distinction in Research
      Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, United States
      2009 - 2014
    • BA, Spanish Literature, Chemistry
      Vanderbilt University, Nashville, TN, United States
      2005 - 2009

    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      AI and Digital Health Innovation
    • Center Member
      Rogel Cancer Center

    Research Overview

    My research focuses on improving the conduct, efficiency, and equity of clinical trials through informatics, infrastructure, and implementation science.

    Recent Publications

     See All Publications
    • Presentation
      Clinical Trial Investigation Across Different Practice Settings: Resources, Review Processes, and Patient Recruitment
      2026 May 10;
    • Journal Article
      Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.
      Lewicki P, Srivastava A, Jiang R, Johnson A, Ghani K, Ginsburg K, Borza T, Stensland K, Salami SS, Davicioni E, Dunn RL, Daignault-Newton S, Palapattu GS, Spratt DE, Cher M, Schipper M, Dess RT, Morgan TM, Singhal U. JNCI Cancer Spectr, 2026 Apr 24; DOI:10.1093/jncics/pkag040
      PMID: 42026952
    • Journal Article
      Editorial Commentary.
      Krischak M, Stensland K. Urol Pract, 2026 Mar; 13 (2): 129 DOI:10.1097/UPJ.0000000000000927
      PMID: 41329825
    • Journal Article
      Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial
      George AK, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Sidana A, Stensland KD, Helfand BT, Gahan JC, Meng X, Yu A, Brisbane WG, Vourganti S, Barqawi AB, Uchio EM, Wysock JS, Polascik TJ, McClure TD, Fainberg J, Coleman JA. European Urology, 2026 Jan 1; 89 (1): 57 - 68. DOI:10.1016/j.eururo.2025.06.003
      PMID: 40685282
    • Journal Article
      Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer
      Miller SR, Chung DH, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Gulati R, Shah Y, Wale D, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2025 Dec 3; 66 (12): 1891 - 1897. DOI:10.2967/jnumed.125.270825
      PMID: 41101975
    • Journal Article
      Rationale and protocol for a prospective clinical trial enrollment improvement hybrid study within a trial
      Lewicki P, Clark S, Shoemaker E, Wang B, Ross J, Daignault-Newton S, Carlozzi N, Martin-Schwarze A, Meurer W, Sales A, Ghani K, Dauw C, Stensland K. Contemporary Clinical Trials Communications, 2025 Dec 1; 48: DOI:10.1016/j.conctc.2025.101548
    • Journal Article
      Predicting long-term risk of prostate cancer mortality following a prostate specific antigen screening test: prognostic model development
      Lewicki P, Jiang R, Radhakrishnan A, Bryant A, Schipper M, Morgan T, Stensland K. Annals of Internal Medicine, 2025 Jun 6;
    • Presentation
      Testing Trial Improvements
      Stensland K. 2026 Jan 28;

    Featured News & Stories

         microscope drawing in navy and yellow with off white background
    Health Lab

    Model predicts long term mortality risk from prostate cancer

    Existing risk calculators for prostate cancer have less accurate estimates or predict risk through tests based on biopsy, which requires tissue samples and extra processing times. U-M researchers have developed a new model that can help doctors and patients understand their PSA results and what it means for patient life expectancy.